The document represents an intimation regarding the availability of an audio recording of the Earnings Call held on September 08, 2026 in relation to the Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2026 (Q1 FY27).
The earnings call was specifically conducted to discuss the company's financial results for the quarter ended June 30, 2026.
The audio recording has been made available on the company's website at www.molbiodiagnostics.com pursuant to Regulation 30 and 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The disclosure was made as a continuation to a previous letter dated September 02, 2026, and was submitted to both BSE Limited and National Stock Exchange of India Ltd for official record.
The document was signed by Darshan Raghunath Karekar, Company Secretary & Compliance Officer (Membership No: F13569), on September 08, 2026 at 17:44:43 IST from Verna-Goa.
Additional Notes Section
This is a compliance filing that does not contain any financial data, performance metrics, or strategic updates beyond the announcement of the earnings call recording availability.
No management participants, presentation materials, or specific discussion topics from the earnings call are disclosed in this document.
The document serves purely as a regulatory compliance notification regarding investor communication materials.
